Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc.

Bullboard Posts

Comment by fredgoodwinsonon Jun 10, 2020 9:37am

164 Views

Post# 31132633

RE:RE:We Deserve To Be Told

Yes that`s right Laser and I stand corrected on the readiness of Rutherrin as GLP (Good Laboratory Practice) was yet to be completed on the last update. Just don’t see any connect with the NMIBC Trial.

It’s fair to say that nothing that they used to tell us would hold the sp up for long but it was good for the morale of longs. With little on the near horizon to look forward to a Company Presentation might be in order.

Bullboard Posts

How one company is disrupting PoC testing